Merck SG&A Expenses 2010-2024 | MRK

Merck sg&a expenses for the twelve months ending June 30, 2024 were $10.545B, a 1.51% increase year-over-year.

  • Merck annual sg&a expenses for 2023 were $10.504B, a 4.6% increase from 2022.
  • Merck annual sg&a expenses for 2022 were $10.042B, a 4.24% increase from 2021.
  • Merck annual sg&a expenses for 2021 were $9.634B, a 7.58% increase from 2020.

Merck SG&A Expenses 2010-2024 | MRK

  • Merck annual sg&a expenses for 2023 were $10.504B, a 4.6% increase from 2022.
  • Merck annual sg&a expenses for 2022 were $10.042B, a 4.24% increase from 2021.
  • Merck annual sg&a expenses for 2021 were $9.634B, a 7.58% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M